April 25 |
|
|
12.00 - 12.10 |
Welcome |
Asgeir Jakola, Gothenburg/Sweden |
|
Cognition - Chair - Anneli Ozanne |
|
12.10 - 12.40 |
Cognitive rehabilitation - lessons learned |
Karin Gehring, Tillburg/The Netherlands |
12.40 - 12.47 |
Abstracts |
|
12.50 - 13.05 |
Cognitive trajectories in IDH mut glioma |
Isabelle Rydén, Gothenburg/Sweden |
|
Brain tumor diagnosis; beyond clinical routine - Chair - Bjarne W. Kristensen |
|
13.10 - 13.40 |
Liquid biopsies |
Susan Short, Leeds/UK |
13.40 - 14.00 |
Brain Cancer: From Biology to Early Detection |
Petra Hamerlik, Manchester/UK |
14.00 - 14.15 |
DNA methylation analysis of liquid biopsies in brain tumors |
Kirsi Rautajoki, Finland |
14.15 - 14.30 |
PET in diagnosis of brain tumors |
Ian Law, Copenhagen/DK |
14.30 - 14.37 |
Abstract |
|
14.40 - 14.55 |
Metabolic patterns before glioma diagnosis |
Sebastian Löding, Umeå/Sweden |
14.55 - 15.15 |
Coffee/Exhibition |
|
|
Radiotherapy - Chair - Maria Sandström |
|
15.15 - 15.30 |
Novel PET tracers in mangement of brain metastasis |
Pirjo Laakkonen, Helsinki/Finland |
15.30 - 15.45 |
Swedish proton experience in LGG / PRO GLIO UPDATE |
Malin Blomstrand, Gothenburg/Sweden |
15.45 - 15.52 |
Abstracts |
|
15.55 - 16.25 |
Experience of intraoperative radiotherapy |
Klaus Henning Kahl, Augsburg/Germany |
|
Tumor microenvironment - Chair - Kirsi Rautajoki |
|
16.30 - 17.00 |
Tumor-host interdependance |
Vidhya Madapusi Ravi, Freiburg/Germany |
17.00 - 17.15 |
Tertiary lymphoid structures; relevance in brain tumors? |
Anna Dimberg, Uppsala/Sweden |
17.15 - 17.30 |
Tumor surfaceome - the key to effective immunotherapy? |
Mattias Belting, Lund/Sweden |
17.30 - 17.45 |
Influence of the microenvironment on chemosensitivity in glioblastoma |
Rikke Frydendahl Sick Olsen, Odense/Denmark |
17.45 - 18.00 |
Coffee/Exhibition |
|
|
New concepts in IDH mutant gliomas |
|
18.00 - 18.30 |
Vorasidenib in IDH mutated gliomas |
Roberta Ruda, Turin/Italy |
|
|
|
April 26
|
|
|
|
Meningiomas - Chair - Anneli Ozanne |
|
08.30 - 08.45 |
Epidemiology and Incidental meningiomas |
Olivia Näslund, Gothenburg/Sweden |
08.45 - 09.15 |
Molecular classification of meningiomas |
Felix Sahm, Heidelberg/Germany |
09.15 - 09.30 |
Radiotherapy as primary option for meningiomas |
Bente Sandvei Skeie, Bergen/Norway |
09.30 - 09.45 |
Copenhagen meningioma score |
Tiit Mathiesen, Copenhagen/Denmark |
09.45 - 09.52 |
Abstract |
|
09.52 - 09.59 |
Abstract |
|
10.00 - 10.07 |
Abstract |
|
10.07 - 10.14 |
Abstract |
|
10.15 - 10.45 |
Meningiomas, new horizons |
Thomas Graillon, Marseille/France |
11.00 - 12.00 |
Poster viewing - Guided |
|
12.00 - 13.00 |
Lunch |
|
|
Innovative study designs - Chair - Jiri Bartek |
|
13.00 - 13.20 |
Register randomized trials - what can neuro-oncology learn from the BROKEN-SWEDEHEART? |
Elmir Omerovic, Gothenburg/Sweden |
13.20 - 13.40 |
Window-of-opprtunity studies |
Michael Vogelbaum, Tampa/USA |
13.40 - 14.00 |
Basket and umbrella trials |
Ulrik Lassen, Copenhagen/Denmark |
|
Basic research topic - Chair - Helena Carén |
|
14.15 - 14.30 |
Spatial organization of diffuse gliomas |
Aliisa Tiihonen, Finland |
14.30 - 14.45 |
GBM organoids, how and why |
Magnar Bjørås, Trondheim/Norway |
14.45 - 15.00 |
3D chromatin organization of the glioblastoma genome |
Silvia Remeseiro, Umeå/Sweden |
15.00 - 15.15 |
Novel insight into glioblastoma heterogeneity |
Bjarne W. Kristensen, Copenhagen/Denmark |
15.15 - 15.22 |
Abstract |
|
15.22 - 15.29 |
Abstract |
|
15.30 - 16.00 |
Coffee/Exhibition |
|
|
Novel therapies |
|
16.00 - 16.30 |
Immunotherapies including CAR-T in neuro-oncology |
Magnus Essand, Uppsala/Sweden |
16.30 - 17.00 |
Neurosurgical role in oncological therapy: towards truly multidisciplinary treatment? |
Michael Vogelbaum, Tampa/USA |
|
|
|
19.00 - 22.00 |
CONGRESS DINNER |
|
|
|
|
April 27 |
|
|
|
ABSTRACT SESSION and quality of life - Chair - Anja Smits |
|
09.00 - 09.10 |
Best abstract clincal |
|
09.10 - 09.20 |
Best abstract clincal |
|
09.20 - 09.35 |
Reproductive health and sexuality |
Claudia Lampic, Umeå/Sweden |
09.35 - 09.50 |
Feasibility of shared decision making in neuro-oncology |
Helle Sørensen Von Essen, Odense/Denmark |
09.50 - 10.00 |
Functional consequences of SMA and M1 resections |
Mattias Stålnacke, Umeå/Sweden |
10.00 - 10.10 |
Support to patients with glioblastoma and their proxies |
Pernilla Ståhl, Gothenburg/Sweden |
10.10 - 10.30 |
Coffee/Exhibition |
|
|
Glioma origin and growth - Chair - Magnus Olivecrona |
|
10.30 - 10.37 |
Best abstract basic |
|
10.37 - 10.45 |
Best abstract basic |
|
10.45 - 11.00 |
Are gliomas inheritable? |
Adam Rosenbaum, Umeå/Sweden |
11.00 - 11.15 |
Glioma invasion: what can we learn from current models? |
Sven Nelander, Uppsala/Sweden |
|
Trial updates with focus on the Nordics - Chair -Roger Henriksson |
|
11.20 - 11.27 |
Abstract |
|
11.28 - 11.35 |
Abstract |
|
11.35 - 11.50 |
Temozolamide and Lomustine in MGMT methylated glioblastoma |
Annika Malmström, Linköping/Sweden |
11.50 - 12.45 |
Lunch |
|
|
Trial updates with focus on the Nordics continues… |
|
12.45 - 13.00 |
Optimized PCNSL treatment with BBB disruption |
Hanne Kuitunen, Oulo/Finland |
13.00 - 13.15 |
Scandinavian standard of care in surgical management of LGG |
Margret Jensdottir, Stockholm/Sweden |
13.15 - 13.30 |
Skull remodelling to improve TTF |
Anders Korshøj, Aarhus/Denmark |
13.30 - 13.45 |
Norwegian Brain Tumor Consortium: improved access to trials |
Petter Brandal, Oslo/Norway |
13.45 - 14.00 |
Tumor deliniation, novel fluorescent agents |
Jane S. Rasmussen, Copenhagen/Denmark |
14.00 - 14.10 |
ADJOURN |
Asgeir Jakola, Gothenburg/Sweden |